Melanocortin-3 receptor regulates the normal fasting response

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 23, 2012, Pages

  Renquist, Benjamin J ^a,e   Murphy, Jonathan G ^b   Larson, Emily A ^c   Olsen, Dawn ^c,d   Klein, Robert F ^c,d   Ellacott, Kate L J ^a   Cone, Roger D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

Corticotrophin releasing hormone; Energy homeostasis; Hormone sensitive lipase; Nonesterified fatty acid

Indexed keywords

CORTICOSTERONE; MELANOCORTIN 3 RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CUSHING SYNDROME; DIET RESTRICTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIPID LIVER LEVEL; LIPOLYSIS; MALE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; PHENOTYPE; PRIORITY JOURNAL; REFEEDING; REGULATORY MECHANISM; WHITE ADIPOSE TISSUE;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE, WHITE; ADIPOSITY; ADRENAL GLANDS; ANALYSIS OF VARIANCE; ANIMALS; BIOMECHANICS; BLOTTING, WESTERN; BODY COMPOSITION; CORTICOSTERONE; ENERGY METABOLISM; FASTING; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIPOLYSIS; LIVER; MALE; MICE; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MELANOCORTIN, TYPE 3; TRIGLYCERIDES;

ANIMALIA; MUS;

EID: 84861905118     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201994109     Document Type: Article

References (56)

1. Huszar D, et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141. (Pubitemid 27180337)
2. Vaisse C, Clement K, Guy-Grand B, Froguel P (1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20:113-114. (Pubitemid 28455439)
3. Yeo GS, et al. (1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20:111-112. (Pubitemid 28455438)
4. Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8:571-578.
5. Roselli-Rehfuss L, et al. (1993) Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90:8856-8860. (Pubitemid 23306409)
6. CaltonMA, et al. (2009) Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum Mol Genet 18:1140-1147.
7. Bagnol D, et al. (1999) Anatomy of an endogenous antagonist: Relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 19:RC26.
8. 3 receptor. Eur J Pharmacol 660:13-20.
9. Bruun JM, Lihn AS, Pedersen SB, Richelsen B (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): Implication of macrophages resident in the AT. J Clin Endocrinol Metab 90: 2282-2289. (Pubitemid 40586275)
10. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100:7265-7270. (Pubitemid 36706427)
11. Ellacott KL, Murphy JG, Marks DL, Cone RD (2007) Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology 148:6186-6194. (Pubitemid 350146148)
12. Nogueiras R, et al. (2007) The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 117:3475-3488. (Pubitemid 350097003)
13. Butler AA, et al. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518-3521. (Pubitemid 32269044)
14. Chen AS, et al. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102.
15. Sutton GM, et al. (2006) Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147:2183-2196.
16. Trevaskis JL, et al. (2007) Role of adiponectin and inflammation in insulin resistance of Mc3r and Mc4r knockout mice. Obesity (Silver Spring) 15:2664-2672.
17. Ni XP, Pearce D, Butler AA, Cone RD, Humphreys MH (2003) Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest 111:1251-1258. (Pubitemid 36519942)
18. Begriche K, Sutton GM, Fang J, Butler AA (2009) The role of melanocortin neuronal pathways in circadian biology: A new homeostatic output involving melanocortin-3 receptors? Obes Rev 10(Suppl 2):14-24.
19. Contreras P, Araya V (1995) [Cushing's syndrome: Review of a national caseload]. Rev Med Chil 123:350-362.
20. Dhillo WS, et al. (2003) Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland. Biochem Biophys Res Commun 301:102-107. (Pubitemid 36268854)
21. Sainsbury A, et al. (1997) Chronic central neuropeptide Y infusion in normal rats: Status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40:1269-1277. (Pubitemid 27469666)
22. Xiao E, Xia-Zhang L, Vulliémoz NR, Ferin M, Wardlaw SL (2003) Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate. Endocrinology 144:1736-1741. (Pubitemid 36543310)
23. Coppola A, et al. (2007) A central thermogenic-like mechanism in feeding regulation: An interplay between arcuate nucleus T3 and UCP2. Cell Metab 5:21-33. (Pubitemid 44939398)
24. Björntorp P, Rosmond R (2000) Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord 24(Suppl 2):S80-S85. (Pubitemid 30461955)
25. Ahn JD, Dubern B, Lubrano-Berthelier C, Clement K, Karsenty G (2006) Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 147:3196-3202. (Pubitemid 43901110)
26. Farooqi IS, et al. (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106:271-279. (Pubitemid 30483131)
27. Klein RF, et al. (2004) Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303:229-232. (Pubitemid 38057572)
28. Klein RF, et al. (2001) Phenotypic characterization of mice bred for high and low peak bone mass. J Bone Miner Res 16:63-71. (Pubitemid 32046189)
29. Zhang Y, et al. (2005) Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J 19:1482-1491. (Pubitemid 41279007)
30. Alon T, et al. (2009) Transgenic mice expressing green fluorescent protein under the control of the corticotropin-releasing hormone promoter. Endocrinology 150: 5626-5632.
31. Stanley S, et al. (2010) Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically. Proc Natl Acad Sci USA 107:7024-7029.
32. Bowers RR, et al. (2004) Sympathetic innervation of white adipose tissue and its regulation of fat cell number. Am J Physiol Regul Integr Comp Physiol 286: R1167-R1175. (Pubitemid 38661406)
33. Shi H, Bartness TJ (2001) Neurochemical phenotype of sympathetic nervous system outflow from brain to white fat. Brain Res Bull 54:375-385. (Pubitemid 32288718)
34. Chen HC, Stone SJ, Zhou P, Buhman KK, Farese RV, Jr. (2002) Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes 51:3189-3195. (Pubitemid 35246964)
35. Franckhauser S, et al. (2002) Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 51:624-630. (Pubitemid 34760168)
36. Haemmerle G, et al. (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312:734-737.
37. Shi H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025. (Pubitemid 44684486)
38. Suganami T, et al. (2007) Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 354:45-49. (Pubitemid 46123196)
39. Marks DL, Butler AA, Turner R, Brookhart G, Cone RD (2003) Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 144:1513-1523. (Pubitemid 36428494)
40. Luquet S, Phillips CT, Palmiter RD (2007) NPY/AgRP neurons are not essential for feeding responses to glucoprivation. Peptides 28:214-225. (Pubitemid 46176250)
41. Mountjoy KG, Bird IM, Rainey WE, Cone RD (1994) ACTH induces up-regulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol Cell Endocrinol 99:R17-R20. (Pubitemid 24048400)
42. Penhoat A, Jaillard C, Saez JM (1989) Corticotropin positively regulates its own receptors and cAMP response in cultured bovine adrenal cells. Proc Natl Acad Sci USA 86:4978-4981. (Pubitemid 19182218)
43. Bicknell AB, Lomthaisong K, Gladwell RT, Lowry PJ (2000) Agouti related protein in the rat adrenal cortex: Implications for novel autocrine mechanisms modulating the actions of pro-opiomelanocortin peptides. J Neuroendocrinol 12: 977-982.
44. Doghman M, et al. (2004) Agouti-related protein antagonizes glucocorticoid production induced through melanocortin 4 receptor activation in bovine adrenal cells: A possible autocrine control. Endocrinology 145:541-547. (Pubitemid 38183795)
45. Smart JL, Tolle V, Otero-Corchon V, Low MJ (2007) Central dysregulation of the hypothalamic-pituitary-adrenal axis in neuron-specific proopiomelanocortin-deficient mice. Endocrinology 148:647-659. (Pubitemid 46143168)
46. Raff H, Raff JL, Findling JW (1998) Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 83:2681-2686. (Pubitemid 28493760)
47. Engeland WC, Dallman MF (1975) Compensatory adrenal growth is neurally mediated. Neuroendocrinology 19:352-362.
48. Takeda S, et al. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317. (Pubitemid 35345151)
49. Ducy P, et al. (2000) Leptin inhibits bone formation through a hypothalamic relayAa central control of bone mass. Cell 100:197-207. (Pubitemid 30064908)
50. Bale L, et al. (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress. Nat Genet 24:410-414.
51. Segal-Lieberman G, Trombly DJ, Juthani V, Wang X, Maratos-Flier E (2003) NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting. Am J Physiol Endocrinol Metab 284:E1131-E1139. (Pubitemid 36617459)
52. Savontaus E, Conwell IM, Wardlaw SL (2002) Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res 958:130-138. (Pubitemid 35441220)
53. Wardlaw SL, McCarthy KC, Conwell IM (1998) Glucocorticoid regulation of hypothalamic proopiomelanocortin. Neuroendocrinology 67:51-57. (Pubitemid 28039380)
54. Schweiger M, et al. (2006) Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281: 40236-40241. (Pubitemid 46041828)
55. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509.
56. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics International 11:36-42.